Carbuterol - Docslib

Sign Up
Log In
Upload

Sign Up
Log In
Upload

Home
» Tags
» Carbuterol

Carbuterol

18 December 2020 – to Date)
Commission
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Hexoprenaline: Β-Adrenoreceptor Selectivity in Isolated Tissues from the Guinea-Pig
Quick Screening of Priority Beta-Agonists in Urine Using Automated Turboflow™ - LC/Exactive Mass Spectrometry Thorsten Bernsmann, Peter Fuerst, Michal Godula
Leaflet Bremax.Cdr
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021
United States Patent (19) 11 Patent Number: 6,110,9749 9 Aberg Et Al
EU Transition Strategy for Mdis
Stembook 2018.Pdf
Study Protocol and Statistical Analysis Plan
(12) United States Patent (10) Patent No.: US 8.426,475 B2 Weidner Et Al
2021 Equine Prohibited Substances List
Section B Changed Classes/Guidelines Final Version Date of Issue
Buterol Compounds
Aclidinium for Use in Improving the Quality of Sleep in Respiratory Patients
Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease

Top View

Generic Sample Preparation Combined with High-Resolution Liquid Chromatography–Time-Of-Flight Mass Spectrometry for Unificatio
Statistical Analysis Plan
(12) United States Patent (10) Patent No.: US 8,506,935 B2 Hale Et Al
WO 2014/115127 Al 31 July 20 14 (31.07.2014) W P O P C T
Novel Methods Neue Verfahren Nouvelles Méthodes
Study Protocols
2019 Equine Prohibited Substances List
Review of the Square Box Symbol Uses
Transdermal Device Containing
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Effect of Regular Salbutamol Inhalations in Normal, Atopic, and Asthmatic Subjects
Customs Tariff - Schedule Xxi - 1
PASS Information
Literature Search Strategy for Treatment of Stable
Beta Adrenoceptor Response in Asthma Judith Kathleen1greenacre
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

© 2024 Docslib.org Feedback